Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | FLT3 | P36888 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17215124 | 0.90 | GAA (0.43) | PKMMAPTALDH1A1FLT3GAA | |
| SCHEMBL4996156 | 0.88 | PKM (0.40) | PKMACACBFLT3KDM4ERECQL | |
| SCHEMBL1823685 | 0.83 | LTA4H (0.48) | KDM4E | |
| SCHEMBL7774589 | 0.83 | LMNA (0.49) | ACACBMAPTALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL6656162 | 0.83 | PKM (0.44) | PKMFLT3APPGAAL3MBTL1 | |
| SCHEMBL5514418 | 0.82 | HRH3 (0.44) | GAA | |
| SCHEMBL9570661 | 0.82 | HRH3 (0.44) | GAA | |
| SCHEMBL6574603 | 0.81 | GAA (0.56) | PKMMAPTALDH1A1FLT3GAA | |
| SCHEMBL29194698 | 0.80 | KDM4E (0.47) | ALDH1A1KDM4EGAAMMP3 | |
| SCHEMBL30245956 | 0.80 | KDM4E (0.47) | ALDH1A1KDM4EGAAMMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1123913-B1 | Process for preparing 2-methoxyethoxybenzenes and new 2-methoxyethoxybenzyl cyanides | BAYER CHEMICALS AG (DE) | 2004-04-07 | — | — | EP | disclosed |
| US-6288262-B2 | REACTION OF PHENOL WITH 2-CHLOROETHYL METHYL ETHER WITHOUT POLAR SOLVENT | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-11 | — | — | US | disclosed |
| EP-1123913-A2 | Process for preparing 2-methoxyethoxybenzenes and new 2-methoxyethoxybenzyl cyanides | BAYER AG (DE) | 2001-08-16 | — | — | EP | disclosed |
| US-20010014697-A1 | Process for the preparation of 2-methoxyethoxy-benzenes and novel 2-methoxyethoxy-benzyl cyanides | LANXESS DEUTSCHLAND GMBH (DE) | 2001-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010014697-A1 | Process for the preparation of 2-methoxyethoxy-benzenes and novel 2-methoxyethoxy-benzyl cyanides | TET2, CYCS, TYR | PKM 2179/4885ACACB 813/4885MAPT 3465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.